Avadel Pharmaceuticals Ownership 2024 | Who Owns Avadel Pharmaceuticals Now?
Institutional Ownership
7.66%
Insider Ownership
4.77%
Retail Ownership
87.56%
Institutional Holders
10.00
Avadel Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VIVO CAPITAL, LLC | 4.33% | 5.16% | 3,972,099 | - | - | 55,847,712 | Jun 30, 2024 |
| TRI LOCUM PARTNERS LP | 1.30% | 4.23% | 1,189,518 | 7 | 0.00% | 16,724,623 | Jun 30, 2024 |
| BIOIMPACT CAPITAL LLC | 0.85% | 1.71% | 783,242 | -87,907 | -10.09% | 11,012,383 | Jun 30, 2024 |
| KNOLL CAPITAL MANAGEMENT, LLC | 0.65% | 5.68% | 600,000 | - | - | 8,436,000 | Jun 30, 2024 |
| KNOTT DAVID M JR | 0.36% | 1.87% | 333,000 | - | - | 4,682,000 | Jun 30, 2024 |
| SCHULHOFF & CO INC | 0.15% | 0.87% | 137,000 | - | - | 1,926,220 | Jun 30, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | 0.01% | 0.00% | 9,055 | 9,055 | 100.00% | 127,313 | Jun 30, 2024 |
| 1620 INVESTMENT ADVISORS, INC. | 0.00% | 0.01% | 1,000 | 1,000 | 100.00% | 14,060 | Jun 30, 2024 |
| CWM, LLC | 0.00% | - | 99 | - | - | 1,000 | Jun 30, 2024 |
| HUNTINGTON NATIONAL BANK | - | - | 1 | - | - | 16 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | - | - | - | -53,221 | -100.00% | - | Jun 30, 2024 |
| US BANCORP \DE\ | - | - | - | -18,447 | -100.00% | - | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -35,475 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -17,400 | -100.00% | - | Jun 30, 2024 |
| STATE STREET CORP | - | - | - | -36,844 | -100.00% | - | Jun 30, 2024 |
| COMMONWEALTH EQUITY SERVICES, LLC | - | - | - | -39,307 | -100.00% | - | Jun 30, 2024 |
| MML INVESTORS SERVICES, LLC | - | - | - | -101,931 | -100.00% | - | Jun 30, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | - | - | - | -167 | -100.00% | - | Jun 30, 2024 |
| STIFEL FINANCIAL CORP | - | - | - | -24,876 | -100.00% | - | Jun 30, 2024 |
| FIRST MANHATTAN CO. LLC. | - | - | - | -100 | -100.00% | - | Jun 30, 2024 |
Avadel Pharmaceuticals's largest institutional shareholder is VIVO CAPITAL, LLC, holding 4.33% of the company's total share outstanding, currently valued at $55.85M. The top 10 institutional shareholders own together 7.66% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| KNOLL CAPITAL MANAGEMENT, LLC | 0.65% | 5.68% | 600,000 | - | - | 8,436,000 | Jun 30, 2024 |
| VIVO CAPITAL, LLC | 4.33% | 5.16% | 3,972,099 | - | - | 55,847,712 | Jun 30, 2024 |
| TRI LOCUM PARTNERS LP | 1.30% | 4.23% | 1,189,518 | 7 | 0.00% | 16,724,623 | Jun 30, 2024 |
| KNOTT DAVID M JR | 0.36% | 1.87% | 333,000 | - | - | 4,682,000 | Jun 30, 2024 |
| BIOIMPACT CAPITAL LLC | 0.85% | 1.71% | 783,242 | -87,907 | -10.09% | 11,012,383 | Jun 30, 2024 |
| SCHULHOFF & CO INC | 0.15% | 0.87% | 137,000 | - | - | 1,926,220 | Jun 30, 2024 |
| 1620 INVESTMENT ADVISORS, INC. | 0.00% | 0.01% | 1,000 | 1,000 | 100.00% | 14,060 | Jun 30, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | 0.01% | 0.00% | 9,055 | 9,055 | 100.00% | 127,313 | Jun 30, 2024 |
| CWM, LLC | 0.00% | - | 99 | - | - | 1,000 | Jun 30, 2024 |
| HUNTINGTON NATIONAL BANK | - | - | 1 | - | - | 16 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | - | - | - | -53,221 | -100.00% | - | Jun 30, 2024 |
| US BANCORP \DE\ | - | - | - | -18,447 | -100.00% | - | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -35,475 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -17,400 | -100.00% | - | Jun 30, 2024 |
| STATE STREET CORP | - | - | - | -36,844 | -100.00% | - | Jun 30, 2024 |
| COMMONWEALTH EQUITY SERVICES, LLC | - | - | - | -39,307 | -100.00% | - | Jun 30, 2024 |
| MML INVESTORS SERVICES, LLC | - | - | - | -101,931 | -100.00% | - | Jun 30, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | - | - | - | -167 | -100.00% | - | Jun 30, 2024 |
| STIFEL FINANCIAL CORP | - | - | - | -24,876 | -100.00% | - | Jun 30, 2024 |
| FIRST MANHATTAN CO. LLC. | - | - | - | -100 | -100.00% | - | Jun 30, 2024 |
The largest Avadel Pharmaceuticals shareholder by % of total assets is KNOLL CAPITAL MANAGEMENT, LLC. The company owns 600.00K shares of Avadel Pharmaceuticals (AVDL), representing 5.68% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AMERITAS INVESTMENT PARTNERS, INC. | 0.01% | 0.00% | 9,055 | 9,055 | 100.00% | 127,313 | Jun 30, 2024 |
| 1620 INVESTMENT ADVISORS, INC. | 0.00% | 0.01% | 1,000 | 1,000 | 100.00% | 14,060 | Jun 30, 2024 |
| TRI LOCUM PARTNERS LP | 1.30% | 4.23% | 1,189,518 | 7 | 0.00% | 16,724,623 | Jun 30, 2024 |
| HUNTINGTON NATIONAL BANK | - | - | 1 | - | - | 16 | Jun 30, 2024 |
| CWM, LLC | 0.00% | - | 99 | - | - | 1,000 | Jun 30, 2024 |
| SCHULHOFF & CO INC | 0.15% | 0.87% | 137,000 | - | - | 1,926,220 | Jun 30, 2024 |
| KNOTT DAVID M JR | 0.36% | 1.87% | 333,000 | - | - | 4,682,000 | Jun 30, 2024 |
| VIVO CAPITAL, LLC | 4.33% | 5.16% | 3,972,099 | - | - | 55,847,712 | Jun 30, 2024 |
| KNOLL CAPITAL MANAGEMENT, LLC | 0.65% | 5.68% | 600,000 | - | - | 8,436,000 | Jun 30, 2024 |
| ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | - | - | - | -19 | -100.00% | - | Jun 30, 2024 |
| SIGNATUREFD, LLC | - | - | - | -22 | -100.00% | - | Jun 30, 2024 |
| FIRST MANHATTAN CO. LLC. | - | - | - | -100 | -100.00% | - | Jun 30, 2024 |
| ORG PARTNERS LLC | - | - | - | -129 | -100.00% | - | Jun 30, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | - | - | - | -167 | -100.00% | - | Jun 30, 2024 |
| HARBOR INVESTMENT ADVISORY, LLC | - | - | - | -200 | -100.00% | - | Jun 30, 2024 |
| FIRST HORIZON ADVISORS, INC. | - | - | - | -211 | -100.00% | - | Jun 30, 2024 |
| DAIWA SECURITIES GROUP INC. | - | - | - | -332 | -100.00% | - | Jun 30, 2024 |
| SALEM INVESTMENT COUNSELORS INC | - | - | - | -450 | -100.00% | - | Jun 30, 2024 |
| MACROVIEW INVESTMENT MANAGEMENT LLC | - | - | - | -455 | -100.00% | - | Jun 30, 2024 |
| BFSG, LLC | - | - | - | -500 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Avadel Pharmaceuticals's largest institutional buyer is AMERITAS INVESTMENT PARTNERS, INC.. The company purchased 9.05K stocks of AVDL, valued at $127.31K.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | - | - | - | -12,915,160 | -100.00% | - | Jun 30, 2024 |
| RTW INVESTMENTS, LP | - | - | - | -8,798,558 | -100.00% | - | Jun 30, 2024 |
| POLAR CAPITAL HOLDINGS PLC | - | - | - | -6,753,672 | -100.00% | - | Jun 30, 2024 |
| GENDELL JEFFREY L | - | - | - | -5,708,118 | -100.00% | - | Jun 30, 2024 |
| BRAIDWELL LP | - | - | - | -2,668,549 | -100.00% | - | Jun 30, 2024 |
| WEALTH EFFECTS LLC | - | - | - | -2,264,226 | -100.00% | - | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | - | - | - | -1,910,983 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -1,812,317 | -100.00% | - | Jun 30, 2024 |
| WOODLINE PARTNERS LP | - | - | - | -1,500,524 | -100.00% | - | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | - | - | - | -1,047,275 | -100.00% | - | Jun 30, 2024 |
| SAMSARA BIOCAPITAL, LLC | - | - | - | -967,527 | -100.00% | - | Jun 30, 2024 |
| CHECKPOINT CAPITAL L.P. | - | - | - | -701,387 | -100.00% | - | Jun 30, 2024 |
| PENN CAPITAL MANAGEMENT COMPANY, LLC | - | - | - | -686,606 | -100.00% | - | Jun 30, 2024 |
| ELEQUIN SECURITIES, LLC | - | - | - | -686,606 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | - | - | - | -665,411 | -100.00% | - | Jun 30, 2024 |
| KENNEDY CAPITAL MANAGEMENT LLC | - | - | - | -653,147 | -100.00% | - | Jun 30, 2024 |
| MODERA WEALTH MANAGEMENT, LLC | - | - | - | -600,449 | -100.00% | - | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | - | - | - | -565,000 | -100.00% | - | Jun 30, 2024 |
| ALTIUM CAPITAL MANAGEMENT LP | - | - | - | -553,057 | -100.00% | - | Jun 30, 2024 |
| ALLY BRIDGE GROUP (NY) LLC | - | - | - | -547,036 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Avadel Pharmaceuticals's biggest institutional seller is JANUS HENDERSON GROUP PLC. The company sold -12.92M shares of AVDL, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AMERITAS INVESTMENT PARTNERS, INC. | 0.01% | 0.00% | 9,055 | 9,055 | 100.00% | 127,313 | Jun 30, 2024 |
| 1620 INVESTMENT ADVISORS, INC. | 0.00% | 0.01% | 1,000 | 1,000 | 100.00% | 14,060 | Jun 30, 2024 |
Avadel Pharmaceuticals's largest new institutional shareholder by number of shares is AMERITAS INVESTMENT PARTNERS, INC., purchased 9.05K shares, valued at $127.31K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | - | - | - | -12,915,160 | -100.00% | - | Jun 30, 2024 |
| RTW INVESTMENTS, LP | - | - | - | -8,798,558 | -100.00% | - | Jun 30, 2024 |
| POLAR CAPITAL HOLDINGS PLC | - | - | - | -6,753,672 | -100.00% | - | Jun 30, 2024 |
| GENDELL JEFFREY L | - | - | - | -5,708,118 | -100.00% | - | Jun 30, 2024 |
| BRAIDWELL LP | - | - | - | -2,668,549 | -100.00% | - | Jun 30, 2024 |
| WEALTH EFFECTS LLC | - | - | - | -2,264,226 | -100.00% | - | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | - | - | - | -1,910,983 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -1,812,317 | -100.00% | - | Jun 30, 2024 |
| WOODLINE PARTNERS LP | - | - | - | -1,500,524 | -100.00% | - | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | - | - | - | -1,047,275 | -100.00% | - | Jun 30, 2024 |
| SAMSARA BIOCAPITAL, LLC | - | - | - | -967,527 | -100.00% | - | Jun 30, 2024 |
| CHECKPOINT CAPITAL L.P. | - | - | - | -701,387 | -100.00% | - | Jun 30, 2024 |
| PENN CAPITAL MANAGEMENT COMPANY, LLC | - | - | - | -686,606 | -100.00% | - | Jun 30, 2024 |
| ELEQUIN SECURITIES, LLC | - | - | - | -686,606 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | - | - | - | -665,411 | -100.00% | - | Jun 30, 2024 |
| KENNEDY CAPITAL MANAGEMENT LLC | - | - | - | -653,147 | -100.00% | - | Jun 30, 2024 |
| MODERA WEALTH MANAGEMENT, LLC | - | - | - | -600,449 | -100.00% | - | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | - | - | - | -565,000 | -100.00% | - | Jun 30, 2024 |
| ALTIUM CAPITAL MANAGEMENT LP | - | - | - | -553,057 | -100.00% | - | Jun 30, 2024 |
| ALLY BRIDGE GROUP (NY) LLC | - | - | - | -547,036 | -100.00% | - | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -406,006 | -100.00% | - | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | - | - | - | -399,551 | -100.00% | - | Jun 30, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | - | - | - | -387,770 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | - | - | - | -374,203 | -100.00% | - | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | - | - | - | -322,000 | -100.00% | - | Jun 30, 2024 |
| TWO SEAS CAPITAL LP | - | - | - | -318,240 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -309,712 | -100.00% | - | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | - | - | - | -291,274 | -100.00% | - | Jun 30, 2024 |
| OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | - | - | - | -279,494 | -100.00% | - | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | - | - | - | -249,160 | -100.00% | - | Jun 30, 2024 |
| LORD, ABBETT & CO. LLC | - | - | - | -193,233 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -168,528 | -100.00% | - | Jun 30, 2024 |
| DORSEY WRIGHT & ASSOCIATES | - | - | - | -127,640 | -100.00% | - | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | - | - | - | -126,000 | -100.00% | - | Jun 30, 2024 |
| ROYAL BANK OF CANADA | - | - | - | -122,565 | -100.00% | - | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | - | - | - | -115,041 | -100.00% | - | Jun 30, 2024 |
| MAI CAPITAL MANAGEMENT | - | - | - | -111,605 | -100.00% | - | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -104,227 | -100.00% | - | Jun 30, 2024 |
| MML INVESTORS SERVICES, LLC | - | - | - | -101,931 | -100.00% | - | Jun 30, 2024 |
| SILVERBACK ASSET MANAGEMENT LLC | - | - | - | -100,000 | -100.00% | - | Jun 30, 2024 |
| INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV | - | - | - | -87,375 | -100.00% | - | Jun 30, 2024 |
| LION POINT CAPITAL, LP | - | - | - | -82,500 | -100.00% | - | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | - | - | - | -82,109 | -100.00% | - | Jun 30, 2024 |
| BLACKROCK INC. | - | - | - | -76,442 | -100.00% | - | Jun 30, 2024 |
| IRIDIAN ASSET MANAGEMENT LLC/CT | - | - | - | -72,025 | -100.00% | - | Jun 30, 2024 |
| POLAR ASSET MANAGEMENT PARTNERS INC. | - | - | - | -69,700 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -62,609 | -100.00% | - | Jun 30, 2024 |
| CIBC PRIVATE WEALTH GROUP, LLC | - | - | - | -58,934 | -100.00% | - | Jun 30, 2024 |
| AVANTAX ADVISORY SERVICES, INC. | - | - | - | -55,756 | -100.00% | - | Jun 30, 2024 |
| JPMORGAN CHASE & CO | - | - | - | -53,221 | -100.00% | - | Jun 30, 2024 |
| ROYCE & ASSOCIATES LP | - | - | - | -48,562 | -100.00% | - | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -47,596 | -100.00% | - | Jun 30, 2024 |
| STATE OF WYOMING | - | - | - | -41,267 | -100.00% | - | Jun 30, 2024 |
| EDGE WEALTH MANAGEMENT LLC | - | - | - | -40,000 | -100.00% | - | Jun 30, 2024 |
| GTS SECURITIES LLC | - | - | - | -39,500 | -100.00% | - | Jun 30, 2024 |
| COMMONWEALTH EQUITY SERVICES, LLC | - | - | - | -39,307 | -100.00% | - | Jun 30, 2024 |
| OPPENHEIMER & CO INC | - | - | - | -37,095 | -100.00% | - | Jun 30, 2024 |
| STATE STREET CORP | - | - | - | -36,844 | -100.00% | - | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -35,475 | -100.00% | - | Jun 30, 2024 |
| DIVERSIFY ADVISORY SERVICES, LLC | - | - | - | -32,363 | -100.00% | - | Jun 30, 2024 |
| ADVISORSHARES INVESTMENTS LLC | - | - | - | -31,765 | -100.00% | - | Jun 30, 2024 |
| LPL FINANCIAL LLC | - | - | - | -25,747 | -100.00% | - | Jun 30, 2024 |
| STIFEL FINANCIAL CORP | - | - | - | -24,876 | -100.00% | - | Jun 30, 2024 |
| TOWNSQUARE CAPITAL LLC | - | - | - | -24,800 | -100.00% | - | Jun 30, 2024 |
| AARON WEALTH ADVISORS LLC | - | - | - | -22,642 | -100.00% | - | Jun 30, 2024 |
| CINCTIVE CAPITAL MANAGEMENT LP | - | - | - | -21,749 | -100.00% | - | Jun 30, 2024 |
| CARMICHAEL HILL & ASSOCIATES, INC. | - | - | - | -21,000 | -100.00% | - | Jun 30, 2024 |
| QUANTBOT TECHNOLOGIES LP | - | - | - | -20,915 | -100.00% | - | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -20,700 | -100.00% | - | Jun 30, 2024 |
| US BANCORP \DE\ | - | - | - | -18,447 | -100.00% | - | Jun 30, 2024 |
| BLUE ZONE WEALTH ADVISORS, LLC | - | - | - | -18,000 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -17,400 | -100.00% | - | Jun 30, 2024 |
| RESOURCES INVESTMENT ADVISORS, LLC. | - | - | - | -16,360 | -100.00% | - | Jun 30, 2024 |
| KESTRA ADVISORY SERVICES, LLC | - | - | - | -16,100 | -100.00% | - | Jun 30, 2024 |
| ENVESTNET ASSET MANAGEMENT INC | - | - | - | -15,329 | -100.00% | - | Jun 30, 2024 |
| EXENCIAL WEALTH ADVISORS, LLC | - | - | - | -15,300 | -100.00% | - | Jun 30, 2024 |
| BUCKINGHAM STRATEGIC WEALTH, LLC | - | - | - | -13,710 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | - | - | - | -13,530 | -100.00% | - | Jun 30, 2024 |
| COMPAGNIE LOMBARD ODIER SCMA | - | - | - | -12,000 | -100.00% | - | Jun 30, 2024 |
| WRAPMANAGER INC | - | - | - | -10,637 | -100.00% | - | Jun 30, 2024 |
| CLARO ADVISORS LLC | - | - | - | -10,165 | -100.00% | - | Jun 30, 2024 |
| BAIRD FINANCIAL GROUP, INC. | - | - | - | -10,000 | -100.00% | - | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | - | - | - | -9,785 | -100.00% | - | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | - | - | - | -9,000 | -100.00% | - | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -5,258 | -100.00% | - | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | - | - | - | -4,469 | -100.00% | - | Jun 30, 2024 |
| LARSON FINANCIAL GROUP LLC | - | - | - | -4,000 | -100.00% | - | Jun 30, 2024 |
| CHILTON CAPITAL MANAGEMENT LLC | - | - | - | -3,000 | -100.00% | - | Jun 30, 2024 |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | - | - | - | -2,300 | -100.00% | - | Jun 30, 2024 |
| RHUMBLINE ADVISERS | - | - | - | -1,545 | -100.00% | - | Jun 30, 2024 |
| GAMMA INVESTING LLC | - | - | - | -1,064 | -100.00% | - | Jun 30, 2024 |
| HARTFORD FINANCIAL MANAGEMENT INC. | - | - | - | -1,000 | -100.00% | - | Jun 30, 2024 |
| BANQUE CANTONALE VAUDOISE | - | - | - | -1,000 | -100.00% | - | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -832 | -100.00% | - | Jun 30, 2024 |
| HANTZ FINANCIAL SERVICES, INC. | - | - | - | -785 | -100.00% | - | Jun 30, 2024 |
| BALDWIN BROTHERS LLC/MA | - | - | - | -500 | -100.00% | - | Jun 30, 2024 |
| BFSG, LLC | - | - | - | -500 | -100.00% | - | Jun 30, 2024 |
| MACROVIEW INVESTMENT MANAGEMENT LLC | - | - | - | -455 | -100.00% | - | Jun 30, 2024 |
| SALEM INVESTMENT COUNSELORS INC | - | - | - | -450 | -100.00% | - | Jun 30, 2024 |
| DAIWA SECURITIES GROUP INC. | - | - | - | -332 | -100.00% | - | Jun 30, 2024 |
Avadel Pharmaceuticals's largest sold out institutional shareholder by shares sold is JANUS HENDERSON GROUP PLC, sold -12.92M shares, valued at -, as of undefined.
Avadel Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Morgan Creek Global Equity Long/Short Institutional Fund | 0.37% | 7,225 | - | - | Mar 31, 2024 |
| Brown Capital Management Mutual Funds | 0.27% | 801,024 | - | - | Dec 31, 2023 |
| TEKLA LIFE SCIENCES INVESTORS | 0.20% | 95,101 | - | - | Mar 31, 2024 |
| ROYCE GLOBAL VALUE TRUST, INC. | 0.19% | 35,460 | 35,460 | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENT TRUST | 0.14% | 425,000 | 125,000 | 41.67% | Mar 31, 2024 |
| Tekla World Healthcare Fund | 0.12% | 138,511 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS VARIABLE SERIES I | 0.10% | 36,283 | - | - | Mar 31, 2024 |
| BUFFALO FUNDS | 0.05% | 300,000 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS GLOBAL/INTERNATIONAL FUND, INC. | 0.04% | 96,595 | - | - | Mar 31, 2024 |
| ADVISORS' INNER CIRCLE FUND | 0.04% | 1,000,000 | - | - | Jan 31, 2024 |
| LAZARD FUNDS INC | 0.04% | 1,501,000 | - | - | Mar 31, 2024 |
| RBB Fund Trust | 0.03% | 34,034 | 34,034 | - | Feb 29, 2024 |
| ROYCE MICRO-CAP TRUST, INC. | 0.03% | 13,102 | -7,879 | -37.55% | Mar 31, 2024 |
| AllianzGI Institutional Multi-Series Trust | 0.02% | 2,675 | - | - | Sep 30, 2020 |
| BRANDES INVESTMENT TRUST | 0.02% | 273,202 | 12,193 | 4.67% | Mar 28, 2024 |
| ADVISORS' INNER CIRCLE FUND | 0.02% | 469,401 | - | - | Jan 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.02% | 49,759 | 11,744 | 30.89% | Feb 29, 2024 |
| LAZARD FUNDS INC | 0.01% | 610,000 | - | - | Mar 31, 2024 |
| JANUS INVESTMENT FUND | 0.01% | 4,083,728 | 65,828 | 1.64% | Dec 31, 2023 |
| LAZARD FUNDS INC | 0.01% | 426,000 | - | - | Mar 31, 2024 |
| AdvisorShares Trust | 0.01% | 31,765 | 31,765 | - | Mar 28, 2024 |
| DEUTSCHE DWS VARIABLE SERIES II | 0.01% | 18,916 | - | - | Mar 31, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.01% | 60,741 | -13,564 | -18.25% | Mar 28, 2024 |
| Franklin Alternative Strategies Funds | 0.00% | 1,459,000 | - | - | Feb 29, 2024 |
| PACE SELECT ADVISORS TRUST | 0.00% | 500,000 | - | - | Jan 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 42,258 | - | - | Mar 28, 2024 |
| Franklin Alternative Strategies Funds | 0.00% | 757,000 | - | - | Feb 29, 2024 |
| Franklin Alternative Strategies Funds | 0.00% | 597,000 | - | - | Feb 29, 2024 |
| North Square Investments Trust | 0.00% | 6,859 | - | - | Jan 31, 2024 |
| CALAMOS INVESTMENT TRUST/IL | 0.00% | 72,340 | - | - | Jan 31, 2024 |
| Franklin Alternative Strategies Funds | 0.00% | 370,000 | - | - | Feb 29, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 31,020 | -56,769 | -64.67% | Feb 29, 2024 |
| RBB FUND, INC. | 0.00% | 34,030 | 34,030 | - | Feb 29, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 54,468 | - | - | Feb 29, 2024 |
| Fidelity Rutland Square Trust II | 0.00% | 318,564 | - | - | Feb 29, 2024 |
| SPDR INDEX SHARES FUNDS | 0.00% | 36,844 | 6,538 | 21.57% | Mar 31, 2024 |
| TRUST FOR PROFESSIONAL MANAGERS | 0.00% | 21,380 | 12,700 | 146.31% | Feb 29, 2024 |
| ETF Series Solutions | 0.00% | 1,335 | - | - | Jan 31, 2024 |
| AIM INVESTMENT FUNDS (INVESCO INVESTMENT FUNDS) | 0.00% | 524,133 | - | - | Jan 31, 2024 |
| PROSHARES TRUST | 0.00% | 6,673 | 982 | 17.26% | Feb 29, 2024 |
| AIM VARIABLE INSURANCE FUNDS (INVESCO VARIABLE INSURANCE FUNDS) | 0.00% | 39,987 | - | - | Mar 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 5,245 | 1,203 | 29.76% | Feb 29, 2024 |
| Investment Managers Series Trust II | 0.00% | 199 | - | - | Mar 31, 2024 |
| COLUMBIA FUNDS SERIES TRUST I | 0.00% | 21,400 | - | - | Feb 29, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 171 | - | - | Jan 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 1,300 | - | - | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 1,800 | - | - | Mar 31, 2024 |
| MUTUAL FUND SERIES TRUST | 0.00% | 2,500 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 7,525 | -2,365 | -23.91% | Jan 31, 2024 |
Avadel Pharmaceuticals's largest mutual fund holder by % of total assets is "Morgan Creek Global Equity Long/Short Institutional Fund", owning 7.22K shares, compromising 0.37% of its total assets.
Avadel Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 10 | -92.42% |
| 31 Mar, 24 | 132 | 8.20% |
| 31 Dec, 23 | 122 | 11.93% |
| 30 Sep, 23 | 109 | -1.80% |
| 30 Jun, 23 | 111 | 11.00% |
| 31 Mar, 23 | 100 | 3.09% |
| 31 Dec, 22 | 97 | 16.87% |
| 30 Sep, 22 | 83 | -3.49% |
| 30 Jun, 22 | 86 | -10.42% |
| 31 Mar, 22 | 96 | -2.04% |
| 31 Dec, 21 | 98 | 2.08% |
| 30 Sep, 21 | 96 | 6.67% |
| 30 Jun, 21 | 90 | - |
| 31 Mar, 21 | 90 | 2.27% |
| 31 Dec, 20 | 88 | 4.76% |
| 30 Sep, 20 | 84 | - |
| 30 Jun, 20 | 84 | 10.53% |
| 31 Mar, 20 | 76 | 52.00% |
| 31 Dec, 19 | 50 | 4.17% |
| 30 Sep, 19 | 48 | 14.29% |
| 30 Jun, 19 | 42 | -2.33% |
| 31 Mar, 19 | 43 | -20.37% |
| 31 Dec, 18 | 54 | -19.40% |
| 30 Sep, 18 | 67 | -15.19% |
| 30 Jun, 18 | 79 | -7.06% |
| 31 Mar, 18 | 85 | 3.66% |
| 31 Dec, 17 | 82 | - |
| 30 Sep, 17 | 82 | 7.89% |
| 30 Jun, 17 | 76 | 7.04% |
| 31 Mar, 17 | 71 | 1083.33% |
| 31 Dec, 16 | 6 | - |
As of 30 Jun 24, 10 institutions are holding Avadel Pharmaceuticals's shares, representing a decrease of -92.42% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 7,025,014 | -89.75% |
| 31 Mar, 24 | 68,522,967 | 22.31% |
| 31 Dec, 23 | 56,021,760 | 3.17% |
| 30 Sep, 23 | 54,298,994 | 3.04% |
| 30 Jun, 23 | 52,698,646 | 8.91% |
| 31 Mar, 23 | 48,385,506 | 44.80% |
| 31 Dec, 22 | 33,414,921 | 6.59% |
| 30 Sep, 22 | 31,350,409 | -7.03% |
| 30 Jun, 22 | 33,722,317 | -5.98% |
| 31 Mar, 22 | 35,867,749 | 2.71% |
| 31 Dec, 21 | 34,921,839 | 8.96% |
| 30 Sep, 21 | 32,050,389 | -1.51% |
| 30 Jun, 21 | 32,541,855 | -0.19% |
| 31 Mar, 21 | 32,603,763 | 1.86% |
| 31 Dec, 20 | 32,008,480 | 1.70% |
| 30 Sep, 20 | 31,474,918 | -13.20% |
| 30 Jun, 20 | 36,261,600 | 35.01% |
| 31 Mar, 20 | 26,859,005 | 46.10% |
| 31 Dec, 19 | 18,383,972 | -5.09% |
| 30 Sep, 19 | 19,370,744 | 0.26% |
| 30 Jun, 19 | 19,320,090 | -2.04% |
| 31 Mar, 19 | 19,722,162 | -0.25% |
| 31 Dec, 18 | 19,772,187 | -2.89% |
| 30 Sep, 18 | 20,360,869 | -1.03% |
| 30 Jun, 18 | 20,573,720 | -20.46% |
| 31 Mar, 18 | 25,866,591 | -1.87% |
| 31 Dec, 17 | 26,358,189 | -2.93% |
| 30 Sep, 17 | 27,153,402 | -2.00% |
| 30 Jun, 17 | 27,708,239 | -0.60% |
| 31 Mar, 17 | 27,876,398 | 548.22% |
| 31 Dec, 16 | 4,300,449 | - |
Avadel Pharmaceuticals (AVDL) has 7.03M shares outstanding as of 30 Jun 24, down -89.75% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 7.66% | 0.10% |
| 31 Mar, 24 | 85.47% | 2.18% |
| 31 Dec, 23 | 62.68% | 1.27% |
| 30 Sep, 23 | 70.29% | 1.03% |
| 30 Jun, 23 | 82.49% | 1.44% |
| 31 Mar, 23 | 75.74% | 2.63% |
| 31 Dec, 22 | 53.66% | 1.98% |
| 30 Sep, 22 | 52.08% | 1.60% |
| 30 Jun, 22 | 57.12% | 1.54% |
| 31 Mar, 22 | 60.97% | 1.71% |
| 31 Dec, 21 | 59.66% | 1.99% |
| 30 Sep, 21 | 54.71% | 1.77% |
| 30 Jun, 21 | 55.64% | 1.79% |
| 31 Mar, 21 | 55.79% | 1.85% |
| 31 Dec, 20 | 54.88% | 1.88% |
| 30 Sep, 20 | 54.07% | 1.21% |
| 30 Jun, 20 | 66.81% | 1.56% |
| 31 Mar, 20 | 65.42% | 2.72% |
| 31 Dec, 19 | 49.07% | 1.83% |
| 30 Sep, 19 | 51.74% | 1.93% |
| 30 Jun, 19 | 51.72% | 1.86% |
| 31 Mar, 19 | 52.80% | 1.88% |
| 31 Dec, 18 | 52.97% | 1.74% |
| 30 Sep, 18 | 55.17% | 1.76% |
| 30 Jun, 18 | 55.95% | 1.24% |
| 31 Mar, 18 | 67.08% | 1.50% |
| 31 Dec, 17 | 66.98% | 1.46% |
| 30 Sep, 17 | 67.78% | 1.49% |
| 30 Jun, 17 | 67.43% | 1.49% |
| 31 Mar, 17 | 67.38% | 61.99% |
| 31 Dec, 16 | 10.43% | - |
As of 30 Jun 24, Avadel Pharmaceuticals is held by 7.66% institutional shareholders, representing a 0.10% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 3 | -96.05% |
| 31 Mar, 24 | 76 | 40.74% |
| 31 Dec, 23 | 54 | 12.50% |
| 30 Sep, 23 | 48 | -17.24% |
| 30 Jun, 23 | 58 | 11.54% |
| 31 Mar, 23 | 52 | 10.64% |
| 31 Dec, 22 | 47 | 38.24% |
| 30 Sep, 22 | 34 | -17.07% |
| 30 Jun, 22 | 41 | 2.50% |
| 31 Mar, 22 | 40 | - |
| 31 Dec, 21 | 40 | -2.44% |
| 30 Sep, 21 | 41 | 5.13% |
| 30 Jun, 21 | 39 | 8.33% |
| 31 Mar, 21 | 36 | -18.18% |
| 31 Dec, 20 | 44 | 2.33% |
| 30 Sep, 20 | 43 | -28.33% |
| 30 Jun, 20 | 60 | 57.89% |
| 31 Mar, 20 | 38 | 58.33% |
| 31 Dec, 19 | 24 | 33.33% |
| 30 Sep, 19 | 18 | - |
| 30 Jun, 19 | 18 | 63.64% |
| 31 Mar, 19 | 11 | -38.89% |
| 31 Dec, 18 | 18 | -10.00% |
| 30 Sep, 18 | 20 | -31.03% |
| 30 Jun, 18 | 29 | -17.14% |
| 31 Mar, 18 | 35 | -10.26% |
| 31 Dec, 17 | 39 | 14.71% |
| 30 Sep, 17 | 34 | -15.00% |
| 30 Jun, 17 | 40 | -41.18% |
| 31 Mar, 17 | 68 | 1033.33% |
| 31 Dec, 16 | 6 | - |
3 institutional shareholders have increased their position in AVDL stock as of 30 Jun 24 compared to 76 in the previous quarter (a -96.05% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 1 | -96.67% |
| 31 Mar, 24 | 30 | 11.11% |
| 31 Dec, 23 | 27 | 3.85% |
| 30 Sep, 23 | 26 | 8.33% |
| 30 Jun, 23 | 24 | 9.09% |
| 31 Mar, 23 | 22 | - |
| 31 Dec, 22 | 22 | 15.79% |
| 30 Sep, 22 | 19 | -5.00% |
| 30 Jun, 22 | 20 | -13.04% |
| 31 Mar, 22 | 23 | 21.05% |
| 31 Dec, 21 | 19 | -5.00% |
| 30 Sep, 21 | 20 | 25.00% |
| 30 Jun, 21 | 16 | -30.43% |
| 31 Mar, 21 | 23 | 9.52% |
| 31 Dec, 20 | 21 | -4.55% |
| 30 Sep, 20 | 22 | 57.14% |
| 30 Jun, 20 | 14 | -12.50% |
| 31 Mar, 20 | 16 | 128.57% |
| 31 Dec, 19 | 7 | -30.00% |
| 30 Sep, 19 | 10 | 11.11% |
| 30 Jun, 19 | 9 | -35.71% |
| 31 Mar, 19 | 14 | -12.50% |
| 31 Dec, 18 | 16 | -27.27% |
| 30 Sep, 18 | 22 | 4.76% |
| 30 Jun, 18 | 21 | -12.50% |
| 31 Mar, 18 | 24 | 4.35% |
| 31 Dec, 17 | 23 | -8.00% |
| 30 Sep, 17 | 25 | 31.58% |
| 30 Jun, 17 | 19 | 1800.00% |
| 31 Mar, 17 | 1 | - |
| 31 Dec, 16 | - | - |
1 institutional shareholders have reduced their position in AVDL stock as of 30 Jun 24 compared to 30 in the previous quarter (a -96.67% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 10 | -92.42% | 7,025,014 | -89.75% | 7.66% | 0.10% | 3 | -96.05% | 1 | -96.67% |
| 31 Mar, 24 | 132 | 8.20% | 68,522,967 | 22.31% | 85.47% | 2.18% | 76 | 40.74% | 30 | 11.11% |
| 31 Dec, 23 | 122 | 11.93% | 56,021,760 | 3.17% | 62.68% | 1.27% | 54 | 12.50% | 27 | 3.85% |
| 30 Sep, 23 | 109 | -1.80% | 54,298,994 | 3.04% | 70.29% | 1.03% | 48 | -17.24% | 26 | 8.33% |
| 30 Jun, 23 | 111 | 11.00% | 52,698,646 | 8.91% | 82.49% | 1.44% | 58 | 11.54% | 24 | 9.09% |
| 31 Mar, 23 | 100 | 3.09% | 48,385,506 | 44.80% | 75.74% | 2.63% | 52 | 10.64% | 22 | - |
| 31 Dec, 22 | 97 | 16.87% | 33,414,921 | 6.59% | 53.66% | 1.98% | 47 | 38.24% | 22 | 15.79% |
| 30 Sep, 22 | 83 | -3.49% | 31,350,409 | -7.03% | 52.08% | 1.60% | 34 | -17.07% | 19 | -5.00% |
| 30 Jun, 22 | 86 | -10.42% | 33,722,317 | -5.98% | 57.12% | 1.54% | 41 | 2.50% | 20 | -13.04% |
| 31 Mar, 22 | 96 | -2.04% | 35,867,749 | 2.71% | 60.97% | 1.71% | 40 | - | 23 | 21.05% |
| 31 Dec, 21 | 98 | 2.08% | 34,921,839 | 8.96% | 59.66% | 1.99% | 40 | -2.44% | 19 | -5.00% |
| 30 Sep, 21 | 96 | 6.67% | 32,050,389 | -1.51% | 54.71% | 1.77% | 41 | 5.13% | 20 | 25.00% |
| 30 Jun, 21 | 90 | - | 32,541,855 | -0.19% | 55.64% | 1.79% | 39 | 8.33% | 16 | -30.43% |
| 31 Mar, 21 | 90 | 2.27% | 32,603,763 | 1.86% | 55.79% | 1.85% | 36 | -18.18% | 23 | 9.52% |
| 31 Dec, 20 | 88 | 4.76% | 32,008,480 | 1.70% | 54.88% | 1.88% | 44 | 2.33% | 21 | -4.55% |
| 30 Sep, 20 | 84 | - | 31,474,918 | -13.20% | 54.07% | 1.21% | 43 | -28.33% | 22 | 57.14% |
| 30 Jun, 20 | 84 | 10.53% | 36,261,600 | 35.01% | 66.81% | 1.56% | 60 | 57.89% | 14 | -12.50% |
| 31 Mar, 20 | 76 | 52.00% | 26,859,005 | 46.10% | 65.42% | 2.72% | 38 | 58.33% | 16 | 128.57% |
| 31 Dec, 19 | 50 | 4.17% | 18,383,972 | -5.09% | 49.07% | 1.83% | 24 | 33.33% | 7 | -30.00% |
| 30 Sep, 19 | 48 | 14.29% | 19,370,744 | 0.26% | 51.74% | 1.93% | 18 | - | 10 | 11.11% |
| 30 Jun, 19 | 42 | -2.33% | 19,320,090 | -2.04% | 51.72% | 1.86% | 18 | 63.64% | 9 | -35.71% |
| 31 Mar, 19 | 43 | -20.37% | 19,722,162 | -0.25% | 52.80% | 1.88% | 11 | -38.89% | 14 | -12.50% |
| 31 Dec, 18 | 54 | -19.40% | 19,772,187 | -2.89% | 52.97% | 1.74% | 18 | -10.00% | 16 | -27.27% |
| 30 Sep, 18 | 67 | -15.19% | 20,360,869 | -1.03% | 55.17% | 1.76% | 20 | -31.03% | 22 | 4.76% |
| 30 Jun, 18 | 79 | -7.06% | 20,573,720 | -20.46% | 55.95% | 1.24% | 29 | -17.14% | 21 | -12.50% |
| 31 Mar, 18 | 85 | 3.66% | 25,866,591 | -1.87% | 67.08% | 1.50% | 35 | -10.26% | 24 | 4.35% |
| 31 Dec, 17 | 82 | - | 26,358,189 | -2.93% | 66.98% | 1.46% | 39 | 14.71% | 23 | -8.00% |
| 30 Sep, 17 | 82 | 7.89% | 27,153,402 | -2.00% | 67.78% | 1.49% | 34 | -15.00% | 25 | 31.58% |
| 30 Jun, 17 | 76 | 7.04% | 27,708,239 | -0.60% | 67.43% | 1.49% | 40 | -41.18% | 19 | 1800.00% |
| 31 Mar, 17 | 71 | 1083.33% | 27,876,398 | 548.22% | 67.38% | 61.99% | 68 | 1033.33% | 1 | - |
| 31 Dec, 16 | 6 | - | 4,300,449 | - | 10.43% | - | 6 | - | - | - |
Avadel Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Avadel Pharmaceuticals's stock was made by Seurer Jerad G. on May 03 2024, selling - shares at - per share (valued at -).
Avadel Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 12 | - | - |
| Q2 2024 | 1 | 7 | 14.29% |
| Q1 2024 | 4 | - | - |
| Q4 2023 | - | 1 | - |
| Q3 2023 | 8 | 3 | 266.67% |
| Q2 2023 | 5 | - | - |
| Q1 2023 | - | 1 | - |
| Q4 2022 | 3 | - | - |
| Q3 2022 | 7 | 1 | 700.00% |
| Q2 2022 | 9 | - | - |
| Q1 2022 | 1 | - | - |
| Q4 2021 | 3 | - | - |
| Q3 2021 | 5 | 1 | 500.00% |
| Q1 2021 | 1 | - | - |
| Q4 2020 | 4 | 1 | 400.00% |
| Q3 2020 | 20 | - | - |
| Q4 2019 | 9 | 1 | 900.00% |
| Q3 2019 | 5 | - | - |
| Q2 2019 | 3 | - | - |
| Q1 2019 | 11 | - | - |
12 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Avadel Pharmaceuticals's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | - | - |
| Q2 2024 | - | - | - |
| Q1 2024 | 1 | - | - |
| Q4 2023 | - | 1 | - |
| Q3 2023 | 3 | 1 | 300.00% |
| Q2 2023 | 2 | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | 3 | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | 9 | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | - | - |
| Q3 2021 | - | - | - |
| Q1 2021 | - | - | - |
| Q4 2020 | - | - | - |
| Q3 2020 | 14 | - | - |
| Q4 2019 | 6 | 1 | 600.00% |
| Q3 2019 | - | - | - |
| Q2 2019 | - | - | - |
| Q1 2019 | - | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Avadel Pharmaceuticals's stocks.
Avadel Pharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| ITCI | Intra-Cellular Therapies, Inc. |
| EVOK | Evoke Pharma, Inc. |
| ANIP | ANI Pharmaceuticals, Inc. |
| AMRX | Amneal Pharmaceuticals, Inc. |
| AQST | Aquestive Therapeutics, Inc. |
| LFCR | Lifecore Biomedical, Inc. |
| DVAX | Dynavax Technologies Corporation |
| NBIX | Neurocrine Biosciences, Inc. |
| IRWD | Ironwood Pharmaceuticals, Inc. |
| ASRT | Assertio Holdings, Inc. |
| DERM | Journey Medical Corporation |
| ACRX | Talphera, Inc. |
| DCPH | Deciphera Pharmaceuticals, Inc. |
| JUPW | Safety Shot Inc |
| AGRX | Agile Therapeutics, Inc. |
| ALKS | Alkermes plc |
| EGRX | Eagle Pharmaceuticals, Inc. |
AVDL Ownership FAQ
Who Owns Avadel Pharmaceuticals?
Avadel Pharmaceuticals is owned by institutional shareholders (7.66%), insiders (4.77%), and public (87.56%). The largest institutional shareholder of Avadel Pharmaceuticals is VIVO CAPITAL, LLC (4.33% of total shares) and the top mutual fund owner is Morgan Creek Global Equity Long/Short Institutional Fund (0.37% of total shares).
Who are the major institutional shareholders of Avadel Pharmaceuticals?
Avadel Pharmaceuticals's major institutional shareholders are VIVO CAPITAL, LLC, TRI LOCUM PARTNERS LP, BIOIMPACT CAPITAL LLC, KNOLL CAPITAL MANAGEMENT, LLC, and KNOTT DAVID M JR. The top five shareholders own together 7.50% of the company's share outstanding.
How many Avadel Pharmaceuticals shareholders are there?
As of Jun 2024, there are 10 institutional shareholders of Avadel Pharmaceuticals.
What percentage of Avadel Pharmaceuticals is owned by VIVO CAPITAL, LLC?
VIVO CAPITAL, LLC owns 3.97M shares of Avadel Pharmaceuticals, representing 4.33% of the company's total shares outstanding, valued at $55.85M (as of Jun 2024).
What percentage of Avadel Pharmaceuticals is owned by TRI LOCUM PARTNERS LP?
As of Jun 2024, TRI LOCUM PARTNERS LP holds 1.19M shares of Avadel Pharmaceuticals (AVDL), compromising 1.30% of the company, valued at $16.72M.
What percentage of Avadel Pharmaceuticals is owned by BIOIMPACT CAPITAL LLC?
BIOIMPACT CAPITAL LLC is the third largest holder of Avadel Pharmaceuticals. The company owns 783.24K of the company's shares outstanding (worth $11.01M).